Nika Pharmaceuticals Inc.

Nika Pharmaceuticals Inc.

NIKA - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$366.99M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Nika Pharmaceuticals Inc.Nika Pharmaceuticals Inc.-4439.5-24%--
$0.00

Current Fair Value

0% upside

Overvalued by 0% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$366.99 Million
Enterprise Value$366.99 Million
Earnings per Share$0
Beta-2.48
Outstanding Shares1,054,689,224

Return

Return on Equity24.19%ROE
Return on Assets-1566.19%
Return on Invested Capital24.19%

Valuation & Multiples

P/E Ratio-4439.51P/E Ratio
PEG-7068.41PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.35Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT-4413.67
Enterprise Value to Net Income-4414
Total Debt to Enterprise0
Debt to Equity0Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Nika Pharmaceuticals Inc.

0
CEO: Dimitar Slavchev Savov

Nika Pharmaceuticals Inc., a pharmaceutical enterprise headquartered in Henderson, Nevada, focuses on the creation of medications to address a broad spectrum of health conditions. Its research and development efforts target serious disea...